The United Arab Emirates has announced it approved the emergency use for healthcare workers of a coronavirus vaccine still in the final phase of human trials, AFP reports.

“The vaccine will be available to our first line of defence heroes who are at the highest risk of contracting the virus,” tweeted the National Emergency Crisis and Disaster Management Authority (NCEMA) on Monday.

Chinese drug giant Sinopharm began the third phase of trials for a Covid-19 vaccine in the UAE in July, with Emirati officials saying the results have been positive.

“Clinical trials for the third phase are continuing under the strict supervision of medical teams, while following all measures to control the quality, safety and efficacy of the vaccine,” said NCEMA.

“The results of clinical trials in our country are moving on the right path, with all tests being successful so far.” NCEMA said the vaccine has been tested on 31,000 volunteers and only “mild and expected” side effects have been reported, adding that 1,000 test subjects with chronic diseases showed “no complications”.

Opinion

Editorial

Climate choices
Updated 15 Jun, 2026

Climate choices

The country is confronting increasingly volatile weather patterns with consequences for agriculture, infrastructure, public health and economic planning.
Brief opening
15 Jun, 2026

Brief opening

WE have been here before. Throughout the weekend, there was great anticipation that a tentative framework for peace...
Environmental disaster
15 Jun, 2026

Environmental disaster

IT was a heartbreaking sight. A recent news report in these pages carried a picture of a sea turtle lying half ...
Budget presser
Updated 14 Jun, 2026

Budget presser

If the FBR falters, the government will find itself in hot water sooner rather than later.
Muharram precautions
14 Jun, 2026

Muharram precautions

WITH Muharram due to start next week, the authorities have already begun annual exercises to ensure that the ...
Blood bequests
14 Jun, 2026

Blood bequests

WORLD Blood Donor Day offers a moment of “gratitude, advocacy and renewed commitment” for thalassaemia patients...